Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Hormonal contraceptive use in Denmark 2010-2019.

Tytuł:
Hormonal contraceptive use in Denmark 2010-2019.
Autorzy:
Kristensen SI
Lidegaard Ø; .
Źródło:
Danish medical journal [Dan Med J] 2021 May 28; Vol. 68 (6). Date of Electronic Publication: 2021 May 28.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Copenhagen : Danish Medical Association
MeSH Terms:
Contraceptives, Oral, Combined*
Venous Thrombosis*
Adult ; Denmark ; Female ; Humans ; Young Adult
Substance Nomenclature:
0 (Contraceptives, Oral, Combined)
Entry Date(s):
Date Created: 20210601 Date Completed: 20210818 Latest Revision: 20210818
Update Code:
20240105
PMID:
34060463
Czasopismo naukowe
Introduction: Hormonal contraception (HC) celebrates its 60th anniversary this year. Thanks to thousands of scientific studies on these products, we now have solid knowledge about the short- and long-term effects and also the adverse effects of different contraceptive types. The aim of this study was to analyse trends in the use of different types of HC through the latest decade in different age groups of Danish women and to study reasons for any changes.
Methods: Individual-level HC sale statistics were provided from the National Registry of Medicinal Products. All statistics were stated as defined daily doses per 1,000 women per day. Absolute numbers and distributions among users were calculated.
Results: The overall use of HC was stable in women from 15 to 25 years, decreased among women aged 25-34 years and increased among women aged 35 years or more. On average, an increase from 35% to 39% was recorded. Across all age groups, the use of second-generation combined oral contraceptives (COC) has almost completely replaced the use of third- and fourth-generation pills, and from the age of 20 years of age, the use of COC has decreased contrasting a steep increase in use of the hormone-intrauterine device (IUD). The magnitude of this shift increased with increasing age.
Conclusions: Whereas the overall use of hormonal contraception has increased over the latest decade from 35% to 39% among all women aged 15-49 years, hormone-IUDs have increasingly replaced COCs so that they are now dominating among women aged 30 years or more. These changes are expected to have decreased venous thrombosis and menorrhagic complaints in young women substantially.
Funding: Expenses were covered by Department of Gynaecology, Rigshospitalet.
Trial Registration: The Danish Data Protection Agency (R. no. 2015-41-4481).
(Articles published in the DMJ are “open access”. This means that the articles are distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies